FIGURE

Fig. 4

ID

ZDB-FIG-240425-18

Publication

Nieoczym et al., 2024 - A comprehensive assessment of palmatine as anticonvulsant agent - In vivo and in silico studies

Other Figures

All Figure Page

Back to All Figure Page

Fig. 4

Repeated treatment with PALM on the seizure severity (A) and loss of PV-IR neurons (B-E) in the hippocampal fields and DG of PTZ kindled mice (B-CA1; C-CA2; D-CA3 and E-DG). PTZ was given ip at a dose of 35 mg/kg, three times a week (at least 48 h break between treatment). Total number of PTZ injections was 19. PALM (20 and 40 mg/kg) was given ip 30 min prior to PTZ treatment. Control group received 5% Tween + PTZ. Data are shown as means ± SEM, n = 14–15 mice/group. Seizure severity in the respective experimental groups was analysed using two-way ANOVA with repeated measures followed by Dunnett’s multiple comparison test. Immunohistochemical analyses were compared via one-way ANOVA and Dunnett’s post hoc test. * ** p < 0.001 vs. 5% Tween + PTZ-treated group.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Biomed. Pharmacother.